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Int J Geriatr Psychiatry. 2019;1–11.Objectives: Dementia is a major public health problem with important physical,
psychosocial, emotional, and financial consequences for patients, their caregivers,
and society. Since patients prefer to be managed at home, extensive research has
been conducted into effectiveness of psychosocial interventions to support informal
caregivers. The aim of this study was to assess the effectiveness of an in‐home
respite care program.
Methods: In a prospective quasi‐experimental study, 99 dyads who received an in‐
home respite care program were compared at 6 months post‐baseline, with 99
matched dyads receiving standard dementia care. Additionally, the short‐term effect
of the program was evaluated 14 to 15 days post‐intervention. The primary outcome
was caregiver burden. The secondary outcomes were: desire to institutionalize the
patient, caregiver quality of life, and frequency and impact of behavioral problems.
Mixed model analyses were performed to evaluate the impact of the intervention.
Results: After 6 months, no significant difference on caregiver burden was
observed, but intervention group caregivers had a significant lower desire to institu-
tionalize the patient compared with control group caregivers (adj.diff = −0.51;
p = .02). Shortly after the program, intervention group caregivers also had a signifi-
cant lower role strain (adj.diff = 0.75; p = .05), and a lower burden on social and family
life (adj.diff = 0.55; p = .05) compared with baseline.
Conclusions: This study was the first comparative study to investigate effective-
ness of an in‐home respite care program to support informal caregivers of persons
with dementia. The results partly confirm earlier positive findings from explorative
studies.
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Dementia is a major public health issue with important physical,
psychosocial, emotional, and financial consequences for patients,wileyonlinelibrary.com/caregivers, and society.1 In 2016, Alzheimer's Disease International
estimated the worldwide economic cost of dementia to be 818 billion
dollars and expected an increase towards a trillion dollars by 2018.2
Extensive research has been conducted into (cost)‐effectiveness of
pharmacological interventions in dementia treatment.3 Because a cure
is not available in the near future and patients prefer to be managed at© 2019 John Wiley & Sons, Ltd.journal/gps 1
Key points
• Research into the comparative effectiveness of in‐home
respite care—a supportive service to temporary relieve
the informal caregivers from their care responsibilities—
is extremely rare. Therefore, a quasi‐experimental study
was designed to assess the effectiveness of an in‐home
respite care program to support informal caregivers of
persons with dementia.
• Shortly after the program, intervention group caregivers
demonstrated a significant lower role strain and a lower
burden on social and family life compared with baseline.
After 6 months, there was no significant difference in
caregiver burden, but caregivers in the intervention
group had a significant lower desire to institutionalize
the patient.
• This study is the first comparative study to investigate
effectiveness of an in‐home respite care program to
support informal caregivers of persons with dementia.
The results partly confirm earlier positive findings from
explorative studies.
2 VANDEPITTE ET AL.home,4,5 the focus has shifted towards effectiveness (and to a lesser
extent cost‐effectiveness) of psychosocial interventions to support
informal caregivers. Indeed, informal caregivers play a crucial
role in the care and support of community‐dwelling patients with
dementia.6 As a result of this demanding and often highly burden-
some and stressful task, they are at risk of developing several health
problems.7
A recently conducted systematic review of comparative studies
investigated the effectiveness of psychosocial support interventions
on the informal caregiver and the care‐recipient. Psychosocial support
was divided into the following four main categories: psychoeducation,
cognitive behavioral therapy, occupational therapy, and respite care.5
It was concluded that psychoeducational support, cognitive behavioral
therapy, and occupational therapy were effective strategies in improv-
ing well being of both caregiver and recipient, and resulted in addi-
tional societal benefits. However, research into the comparative
effectiveness of respite care, and especially in‐home respite care—
which is defined as a supportive service to give the informal caregiver
a temporary relieve or break from caregiving duties—was rare because
of methodological challenges.5,8-10 Therefore, an additional review,11
which also allowed recent observational designs without control
group, was conducted to investigate the effectiveness of different
types of respite care. In this review, it was concluded that day
care services were effective in decreasing caregiver burden and
behavioral problems in people with dementia, but also accelerated
time to nursing home placement. Results of temporary residential
admission were rather mixed and showed unexpected adverse
effects on both caregivers and care‐recipients (such as reduced
sleep quality in care‐recipients while being admitted, and increased
burden and distress in caregivers shortly after the respite period).
Evidence on community‐based respite care such as in‐home respite
care and host family respite care remained rare. Only one quantitative
in‐home respite care intervention was identified indicating some ben-
efits for caregivers.12
Nevertheless, qualitative research into the potential impact of in‐
home respite care was promising.11,13,14 The provision of respite
responded to an unmet need of many caregivers to take a break.4,15
Caregivers were in general highly satisfied with the provided respite
care.15-19 They described benefits such as lower perceived burden,20
being able to get things done,14 and the possibility to escape from
their duties enabled them to continue their demanding role as care-
giver.16,17 Additionally, some caregivers pointed out their preference
for in‐home respite care, especially because their loved ones could
remain in their trusted environment.14,16
Because explorative research suggests that in‐home respite ser-
vices can actually be important for caregivers but the level of evidence
should be improved, we have designed the (to our knowledge) first
comparative study to assess the effectiveness of a specific 24‐hour/
24‐hour in‐home respite care program. On the basis of the current
evidence, our hypothesis is that in‐home respite care can potentially
reduce caregiver burden, as well as the caregiver's intention to institu-
tionalize the person with dementia, and that it can help manage
behavioral problems.2 | METHODS
Detailed information about the study protocol can be consulted in a
previous publication.21 Ethical approval (B670201526906) was
obtained, and the trial was registered on clinicaltrials.gov, ID:
NCT02630446.2.1 | Design
A quasi‐experimental study was designed to investigate the effective-
ness of an in‐home respite care program on caregivers of persons with
dementia. A quasi‐experimantel design was chosen for practical and
ethical reasons (see further) and because this design was earlier iden-
tified as a favorable and valid strategy to conduct research into respite
care efficacy.8 Comparison between both study arms was done by
collecting health‐related and economic data.2.2 | Participants
To be eligible for the study, the caregivers had to provide informal
care. Hence, professional healthcare workers in the caregiving role
under investigation were not recruited. The caregivers had to identify
themselves as the main person responsible for the informal care (pri-
mary caregiver) and had to fluently understand Dutch or French.
Finally, caregivers with severe cognitive impairment or psychiatric
comorbidity were excluded. The care‐recipient had to be formally
diagnosed with dementia and to reside in the community.
VANDEPITTE ET AL. 32.3 | Recruitment
Informal caregiver and dementia patient dyads for the intervention
arm, ie, receiving the in‐home respite care program (intervention) were
recruited via an independent supportive healthcare service at home
called Baluchon (see further). Informal caregiver and dementia patient
dyads for the control arm were broadly recruited across Belgium, ie,
from six different memory clinics, a geriatric daycare clinic, several
Alzheimer cafés (monthly meeting places for peers), local info points,
and expert centers for dementia, the Flemish Alzheimer's league, a
sickness fund, and 16 general practitioners. Recruitment started in
January 2016 and was completed in December 2017.2.4 | Setting
In each setting, eligible participants were identified by the health care
professionals who then described the study, and asked informal care-
givers if they were willing to participate. After their verbal consent,
contact information was forwarded to the research team who then
contacted them by phone. During this call, a home visit was planned
to sign the informed consent and complete the baseline assessment.2.5 | Intervention
The intervention consisted of a 24‐hour/24‐hour in‐home respite care
program (called Baluchonnage), alongside standard dementia care, and
was provided by an organization named “Baluchon Alzheimer
Belgium.” In this respite program, caregivers could be relieved from
their caregivers's task for at least 5 days while a trained employee took
their place (5 d were offered for free). For the patient, all daily
habits/activities and resource use remained unchanged.
The program also included caregiver support by keeping a support
diary. The latter can be seen as a communication tool between the
caregiver and the Baluchonneuse. In this diary, the trained employee
noted all daily experiences and strategies to better deal with the diffi-
cult behaviors the caregivers listed before. In this way, caregivers
could validate their perceptions, learn to better cope with difficult
behaviors, and felt understood by somebody. Also, after the the
respite period, the trained employee remained available for further
counsel indefinitely.2.6 | Treatment as usual
The control group received usual dementia care (including medical,
psychological, and other health and social services) and other support-
ive initiatives (such as support groups). Only dyads who already
benefitted from the in‐home respite service offered by Baluchon and
those stating at baseline not willing to ever consider this type of sup-
port at baseline were excluded.2.7 | Outcome measures
Assessments were carried out in both groups at baseline during a
home visit. The follow‐up assessment at 6 months was made over
the phone. In the intervention group, an extra assessment was carried
out by phone 14 to 15 days after the last intervention day to evaluate
the short‐term impact.
In both study arms, the baseline data were collected after inclu-
sion. During this baseline assessment, background characteristics
(sociodemographics, clinical data, and resource use of the patient)
were collected, as well as the baseline values on the various outcomes
(see below).
The primary outcome was caregiver self‐perceived burden col-
lected with the Zarit Burden Interview (ZBI). This 22‐item validated
self‐report questionnaire uses a 5‐point Likert scale, ranging from
“never” to “nearly always present.” The final score ranges between 0
(no burden) to 88 (high burden).22
Secondary outcomes were:
• Desire of the caregiver to institutionalize the patient, measured
with a modified version of the Desire‐to‐Institutionalize scale,23
which is known as a reliable predictor for future institutionaliza-
tion.24,25 The scale contains six “yes/no” questions. The higher
the total score (maximum score = 6), the greater the desire.
• Caregiver health–related quality of life was collected with the EQ‐
5D‐5 L, a standardized non‐disease specific value‐based instrument
on the self‐perceived health status.26 The instrument consists of
five health‐related domains (mobility, self‐care, daily activities, pain,
and depression/anxiety), with each domain having five answer cat-
egories, resulting in a 5‐digit health profile. The profile was trans-
lated into a utility value based on a published algorithm.27
• Frequency of behavioral problems in the dementia patients and
impact of those behaviors on the caregiver was measured with
the Revised Memory and Behavior Problems Checklist (RMBPC).28
This validated caregiver self‐report measure contains 24 items,
including three domains (depression, memory‐related problems,
and disruptive behaviors) comprising two scales. One scale mea-
sures, the frequency of problem behaviors of the person with
dementia (ranging from never occurs to occurs daily or more often),
and the other measures, the reactions of the caregiver to these
problematic behaviors (ranging from not at all to extremely).
A timeline of the different assessment moments and outcomes can
be found in Figure 1.2.8 | Power calculation
A sample size calculation was executed in SPSS Sample Power 3 for
the primary outcome caregiver perceived burden. An effect size of
0.4 was defined based on a similar high‐quality trial, which implies a
difference of six points on the ZBI. The standard deviation (SD) was
set at 15.29 To obtain a power of 80% and a significance level at
FIGURE 1 Timeline of assessments within the trial
4 VANDEPITTE ET AL.0.05, each group had to contain 100 dyads. Next, to reduce selection‐
bias inherent to quasi‐experimental studies, an allocation ratio of 1:2
was used to allow propensity score matching (see below) and addition-
ally to deal with drop‐out, an average estimated drop‐out rate of 20%
was considered as well. As such, it was estimated that 124 dyads should
be recruited in the intervention group and 248 in the control group in
order to finally compare 100 dyads in each study arm after 6 months.2.9 | Statistical analyses
First, descriptive statistics were carried out to draw a clear profile
of the characteristics of study participants. To determine possible
baseline differences between the groups, mean values of baseline
characteristics were compared using independent sample t‐tests for
continuous variables if normally distributed or by performing
Pearson's Chi‐square test for categorical variables. To help control
for bias and confounding, propensity score matching (nearest neighbor
method) was carried out.30 Matching between both groups at baseline
was based on variables for which significant baseline differences
were found between both study arms and on variables for which it
was demonstrated in the literature that these were associated with
self‐perceived burden.31,32 These were: age of the informal caregiver,
relationship between caregiver and patient, being on a waiting list
for nursing home placement, severity of dementia, level of depen-
dency, desire to institutionalize the patient, total time spent in caregiv-
ing per day, caregiver burden, frequency of behavioral problems,
impact of behavioral problems on the caregiver, and educational level
of the caregiver.
To investigate possible effects of the intervention at 6 months
of the matched sample, mixed model analyses were carried out for
each outcome separately (defined as dependent variable in the model).To check whether the assumptions had been met, graphical plots of
residuals and predicted values were investigated. A P value of.05
was considered significant. Time (baseline & 6 months' outcomes)
and group (intervention or control group) were defined as fixed factors
in the mixed model, while caregiver unique ID was defined as the ran-
dom factor. When a significant difference in a certain variable was still
present after matching, this was defined as a covariate in the model.
Finally, the propensity score was also included as a covariate. In liter-
ature, this method is described as double propensity‐score adjustment
and is known as a solution for the problem design bias or bias due to
incomplete matching.333 | RESULTS
3.1 | Sample description
A response rate of 77% was reached meaning that, of the 465 care-
givers recruited in the participating settings, 355 eventually completed
the baseline evaluation during a home visit. In total, 252 dyads were
allocated to the control group and 103 to the intervention group.
After propensity score matching, a total of 198 participants
remained eligible for the effectiveness analysis: 99 caregiver/patient
dyads in each study arm. Six months post‐baseline, 149 dyads com-
pleted the primary endpoint. Figure 2 displays the recruitment process
and flow of participants.3.2 | Characteristics of the study participants and
matching
The descriptive statistics of the 198 matched dyads characteristics are
outlined in Table 1. Most caregiver and patient characteristics were
FIGURE 2 Recruitment process and flowchart of participants
VANDEPITTE ET AL. 5well‐balanced after conducting the matching procedure, meaning that
no significant difference remained between both study arms. Patient
age (not used as matching variable) was included in the mixed model
as a covariate because a significant difference between both groups
remained. The overall balance test of Hansen and Bowers34 (to evalu-
ate the matching quality) indicated good overall balance (x2 = 13.08,
p = .60) as well. Only some minor imbalance remained for the level
of dependency of the patient: the standardized mean difference after
matching was 0.27 while the aim is to be below 0.25.35 Therefore,
level of dependency was also included in the mixed model as a
covariate.36
3.3 | Effectiveness of the in‐home respite care
program
Table 2 summarizes average scores at baseline and 6 months post‐
baseline and gives the adjusted estimated effect of the in‐home
respite care program compared with standard dementia care for the
primary and secondary outcomes.
The caregiver burden (primary outcome) did not show a significant
mean difference between intervention and control group (−0.13; 95%
CI, −3.27 to 3.02; p = .94) at 6 months post‐baseline. However, thecaregivers' desire to institutionalize the patient (secondary outcome)
showed a significant mean difference of −0.51 (95% CI, −0.97 to
0.55; p = .023), in favor of the intervention group. More specifically,
in the intervention group, the desire to institutionalize the patient in
residential care decreased after 6 months (from 1.94 [SD = 0.18] to
1.77 [SD = 0.20]) while in the control group, the desire increased (from
2.09 [SD = 0.17] to 2.42 [SD = 0.20]). The effect size of this statisti-
cally significant difference was calculated by dividing the mean differ-
ence between both groups by the pooled standard deviation. On this
basis, this Cohen's d of.3, it can be concluded that the effect is small
but clinically relevant.37
There was no significant mean difference at 6 months post‐base-
line in the caregiver's quality of life (0.01; 95% CI, −0.04 to 0.07;
p = .59). Although caregiver quality of life obtained by the EQVAS in
the intervention group increased (from 67.38 [SD = 2.00] to 70.06
[SD = 1.93]) while it decreased in the control group (from 68.82 [SD
= 1.99] to 67.50 [SD = 1.97]), there was only a trend towards a signif-
icant mean difference after 6 months post‐baseline (4.00; 95% CI,
−1.29 to 9.28; p = .137). Finally, no significant mean difference was
detected for frequency of behavioral problems (−0.01; 95% CI, −0.15
to 0.14; p = .95) and for the impact of those problematic behaviors
on the caregiver (0.01; 95% CI, −0.19 to 0.21; p = .89).
TABLE 1 Characteristics of the study participants
Matched Control
Group N = 99
Matched Intervention
Group N = 99
Total Matched
Group N = 198
Caregiver age in years, mean (SD) 67.15 (12.16) 64.79 (12.17) 65.97 (12.17)
Caregiver gender, % (n)
Female 72% (71) 75% (74) 73% (145)
Region, % (n)
Flanders 67% (66) 22.% (22) 44% (88)
Wallonia 31% (31) 53% (52) 42% (83)
Brussels 2% (2) 25% (25) 14% (27)
Caregiver professional situation, % (n)
Active on the labor market 69% (68) 57% (56) 23% (45)
Non‐active on the labor market 12% (12) 17% (17) 15% (29)
Retired 19% (19) 26% (26) 63% (124)
Multiple caregivers, % (n)
Yes 36% (36) 37% (37) 37% (73)
Change in professional situation (working less hours) to deal with caregiving tasks 9% (9) 22% (22) 16% (31)
Caregiver educational level, % (n)
Low 15% (15) 14% (14) 15% (29)
Middle 30% (30) 21% (22) 26% (52)
High 55% (54) 64% (63) 59% (117)
Caregiver civil state, % (n)
Alone 11% (11) 8% (8) 10% (19)
Married/legal cohabitation 77% (76) 72% (71) 74% (147)
Unmarried 5% (5) 8% (8) 7% (13)
Widow 2% (2) 1% (1) 2% (3)
Divorced 5% (5) 11% (11) 8% (16)
Type of relationship caregiver/person with dementia, % (n)
Partner/spouse 63% (62) 57% (56) 60% (118)
Daughter/son 26% (26) 34% (34) 30% (60)
Other family member or friend 11% (11) 9% (9) 10% (20)
Cohabitation with person with dementia, % (n)
Yes 74% (73) 84% (83) 79% (156)
Caregivers burden, mean (SD) 39.76 (14.36) 41.21 (14.67) 40.48 (14.50)
Caregiver desire to institutionalize the patient, mean (SD) 2.02 (1.84) 2.03 (1.60) 2.03 (1.72)
EQ‐5D index, mean (SD) 0.70 (0.214) 0.72 (0.22) 0.71 (0.22)
EQ‐VAS, mean (SD) 69.2 (18.8) 66.92 (20.37) 68.06 (19.58)
Time spent in caregiving hours/day, mean (SD) 8.82 (6.46) 9.03 (5.75) 8.93 (6.10)
Person with dementia age in years, mean (SD) 77.55 (9.87) 81.35 (8.29) 79.45 (9.29)
Waiting list for residential care, % (n) 43% (43) 47% (46) 44% (89)
Person with dementia gender, % (n)
Female 48% (47) 54% (53) 51% (100)
Person with dementia educational level, % (n)
Low 39% (39) 30% (30) 35% (69)
Middle 28% (28) 20% (20) 25% (48)
High 30% (30) 50% (49) 40% (79)
(Continues)
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TABLE 1 (Continued)
Matched Control
Group N = 99
Matched Intervention
Group N = 99
Total Matched
Group N = 198
Person with dementia civil state, % (n)
Alone 2% (2) 1% (1) 2% (3)
Married/legal cohabitation 67% (66) 57% (56) 62% (122)
Unmarried 3% (3) 3% (3) 3% (6)
Widow 26% (26) 35% (35) 31% (61)
Divorced 2% (2) 4% (4) 3% (6)
Severity of dementia, % (n)
Moderate cognitive decline 12% (12) 10% (10) 11% (22)
Moderately severe cognitive decline 41% (41) 35% (35) 38% (76)
Severe cognitive decline 41% (41) 43% (43) 42% (84)
Very severe cognitive decline 5% (5) 11% (11) 8% (16)
Level of dependency, mean (SD) 19.17 (5.87) 20.47 (6.43) 19.82 (6.18)
Frequency of behavioral problems in the last week, mean (SD) 1.61 (0.50) 1.58 (0.54) 1.59 (0.52)
Impact of behavioral problems on the caregiver in the last week, mean (SD) 1.69 (0.71) 1.78 (0.71) 1.73 (0.71)
Use of Home aid services in the last month (district nurse, home aid, sitting service), % (n)
Yes 67% (66) 84% (83) 75% (149)
Use of accommodation in the last 6 months (short stay, day care, host family), % (n)
Yes 42% (42) 43% (43) 43% (85)
Hospitalization or emergency room visit in the last 6 months, % (n)
Yes 28% (28) 29% (29) 29% (58)
Outpatient visits in the last month, % (n)
Yes 92% (91) 85% (84) 88% (175)
TABLE 2 Primary and secondary outcomes in intervention and control group (results for the mixed model)
Outcomes
Control Group Intervention Group In‐Home Respite Versus Standard Care
Baseline N = 99 6 mo N = 73 Baseline N = 99 6 mo N = 76
Treatment effect adjusted difference,a
(95% CI), P value
Caregiver burden 40.73 (1.33) 41.03 (1.35) 39.95 (1.34) 40.12 (1.33) −0.13 (−3.27 to 3.02), .94
Desire to institutionalize 2.09 (0.17) 2.42 (0.20) 1.94 (0.18) 1.77 (0.20) −0.51 (−0.97 to 0.55), .023b
Caregiver quality of life
EQ 5D (utilities) 0.69 (0.02) 0.67 (0.02) 0.73 (0.02) 0.72 (0.02) 0.01 (−0.04 to 0.07), .59
EQVAS 68.82 (1.99) 67.50 (1.97) 67.38 (2.00) 70.06 (1.93) 4.00 (−1.29 to 9.28), .137
Frequency of behavioral problems 1.61 (0.05) 1.71 (0.06) 1.57 (0.05) 1.67 (0.06) −0.01 (−0.15 to 0.14), .95
Impact of behavioral problems 1.71 (0.06) 1.62 (0.08) 1.74 (0.06) 1.67 (0.08) 0.01 (−0.19 to 0.21), .89
Data are mean (Standard deviation) unless otherwise specified.
aAdjusted for propensity score, level of dependency (KATZ), and age of dementia patient.
bSignificant difference
VANDEPITTE ET AL. 73.4 | Short‐term effect of the in‐home respite care
program
Table 3 summarizes average scores at baseline and 14 to 15 days
post‐intervention in the intervention group and gives the adjusted
estimated time effect for the primary and secondary outcomes.There was no significant effect over time on the total caregiver
burden (−0.01, 95% CI, −1.85 to 1.85; p = .99) between baseline
and 14 to 15 days post‐intervention. However, two burden sub-
scales did show a significant difference over time between baseline
and 14 to 15 days post‐intervention. First of all, there was a signif-
icant time effect of burden on social and family life (0.55; 95% CI,
TABLE 3 Short‐term effects of time in intervention group (results for pairwise comparisons in mixed model)
Outcomes
Intervention Group Post‐Intervention Versus Pre‐Intervention
Baseline N = 99 14‐15 d post‐intervention N = 98 Time effect adjusted differencea, (95% CI), P value
Caregiver burden
Total score 40.35 (1.32) 40.36 (1.34) −0.01 (−1.85 to1.85), .99
Burden on social & family life 7.65 (0.38) 7.10 (0.38) 0.55 (0.01 to 1.09), .047b
Role strain 12.65 (0.53) 11.90 (0.53) 0.75 (−0.01 to 1.50), .052b
Desire to institutionalize 1.96 (0.17) 1.65 (0.18) 0.31 (0.05 to 0.58), .023b
Frequency of behavioral problems 1.58 (0.05) 1.57 (0.05) 0.01 (−0.06 to 0.08), .82
Impact of behavioral problems 1.75 (0.06) 1.64 (0.08) 0.11 (−0.03 to 0.25), .134
Note. Data are mean (standard deviation) unless otherwise specified.
aAdjusted for propensity score, level of dependency (KATZ), and age of dementia patient.
bSignificant difference
8 VANDEPITTE ET AL.0.01‐1.09; p = .047). Another significant effect was found for the
subscale role strain. The caregivers, on 14 to 15 days post‐
intervention, scored significantly lower on this subscale than before
obtaining the in‐home respite support (0.75; 95% CI, −0.01 to
1.50; p = .052). Desire to institutionalize the patient was also signif-
icantly lower 14 to 15 days after obtaining the in‐home respite pro-
gram compared with before (0.31; 95% CI, 0.05‐0.58; p = .023).
Frequency of behavioral problems remained the same before andFIGURE 3 Changes over time in the intervention and control group for th
age & dependency, propensity score)14 to 15 days post‐intervention (0.01; 95% CI, −0.06 to 0.08;
p = .82). Finally, the decrease in the extent to which the caregiver
was affected by the behavioral problems shortly after the interven-
tion compared with before was not significant (0.11; 95% CI,
−0.03 to 0.25; p = .134).
Figure 3 displays the changes over time in the intervention and
control group for the primary and secondary outcomes adjusted for
propensity score, patient age, and patient level of dependency.e primary and secondary outcomes (mean scores, adjusted for patient
VANDEPITTE ET AL. 94 | DISCUSSION
Our study shows that informal caregivers of persons with dementia
benefitted partially from a temporary in‐home respite care program
shortly after the respite episode (14‐15 d) and 6 months later.
After 6 months, the intervention group had a significant lower
desire to institutionalize the person with dementia. Shortly after
the respite episode, the intervention group reported not only a sig-
nificant lower desire to institutionalize the person with dementia,
but also a significant lower role strain and a lower burden on social
and family life.
The finding that the desire to institutionalize (DIS) significantly
decreased in the intervention group after 6 months is important.
Indeed, DIS is a well‐known valid proxy for predicting time to actual
placement.38 When caregivers have a lower DIS, they can better
maintain their role, and dementia patients can remain longer in
their trusted environment. The latter is preferred because staying
home is associated with better patient quality of life and less
morbidity. Moreover, institutionalization puts more financial
pressure on the healthcare budget. Research has proven also that
lower DIS is associated with lower burden, and with being able
to better cope with the behavioral problems of the dementia
patient.39 However, our trial did not reveal a significantly reduced
caregiver burden nor improved coping with behavioral problems.
One may assume that with a larger sample size, such a significant
effect might have been found. But when considering the p values,
it is unlikely that a significant or clinically meaningfull effect
would have been found in the primary outcome. Only for the quality
of life outcome, for which a clear trend of improvement in the inter-
vention arm was observed, a larger sample size might have led to a
significant result.
This study was the first comparative study to investigate effec-
tiveness of this specific in‐home respite care program to support
informal caregivers of persons with dementia. The results partly con-
firmed earlier positive findings from explorative qualitative studies
into the potential benefits of respite care (ie, reduced stress, being
able to maintain role, and lower strain).14,16,19,20 We believe the
study has moreover some methodological strengths. First, a quasi‐
experimental trial was set up for practical and ethical reasons and
because this design was earlier identified as a favorable and valid
strategy to conduct research into respite care efficacy.8 Indeed, it
can be seen as ethically unacceptable to randomly assign dyads to
one of the trial arms withholding control group dyads to receive
the program for 1 year after first informing them about the possibil-
ity of getting this support for free. Also, because there is no plausi-
ble placebo alternative for the intervention, participants allocated to
a control group in a randomized way would have been more prone
to drop out. Second, to avoid bias and confounding inherent to
quasi‐experimental studies that lack random assignment of partici-
pants, a propensity score matching was performed. In this way, we
tried to come close to an RCT setting and effects could be assigned
to the intervention. Third, to further improve internal validity, we
have only included participants in the control group that hadindicated that they were prepared to utilize in‐home respite care.
Fourth, internationally validated questionnaires were used. These
were adapted to the Belgian context when needed, and forward‐
back translations were performed when no Dutch or French version
existed. Fifth, active components of the intervention are clearly
described, and drop‐out or termination of participation was docu-
mented. A sixth methodological strength was the fact that the first
assessment was conducted during a home visit. Face‐to‐face
interviewing remains the preferred type of data collection for this
type of projects and could be the explanation for the very low
drop‐out rate present in this trial.
Some limitations also need to be mentioned. First, although a pro-
pensity score matching was performed, there remains a risk towards
internal validity because unmeasured confounders could still be pres-
ent. For example, in this trial, the duration since diagnosis of dementia
was not considered. A second limitation is that only participants will-
ing to consider in‐home respite were allowed in this trial. As such,
we cannot speculate whether effects would have been different for
caregivers not willing or not asking for this kind of support on their
own initiative. Third, as in many trials, participants with lower socio-
economic status and low educational level may be underrepresented.
Possibly, we were not able to include those most in need for support.
However, the fact that intervention group participants got 5 days of
the program for free might have alleviated this problem to a certain
level and have attracted families who would probably not have consid-
ered the service before because of financial reasons. Indeed, as this
service is not reimbursed, this would have come with a considerable
cost for the caregiver. A fourth limitation is that we did not control
for the exact duration of the intervention. Even by setting a minimum
duration of 5 days as an inclusion criterion, differences in outcome
variables can still be caused by differences in duration. However, the
variation in duration remained limited: 65% of the sample received
the intervention during 5 to 10 days. The average was 9.2 days, and
the maximum duration was 17 days. Fifth, as in many supportive care-
giver interventions, the rather limited duration of the trial and short
follow‐up can be considered a weakness. Because dementia is a
slow degenerative process, it is to be expected that differences in
time to placement are not to be found on such short notice. However,
to alleviate this problem we have used the desire to institutionalize
scale, which is a valid proxy for actual placement. Sixth, as discussed
above, the trial did only reach 73% of the intended sample size
of 100 dyads in each study arm at 6 months. Seventh, in contrast to
earlier respite care studies (especially into temporary residential
admission11), we did not detect any adverse effects of the program
in the primary and secondary research outcomes. Nevertheless, it
could be interesting to expand current evidence with an additional
quantitative and/or qualitative study into the potential negative
effects (such as reduced sleep and increased deterioration) and nega-
tive experiences of caregivers and care‐recipients. Finally, in order to
allow policy makers to make an informed decision on whether to
adopt this service into standard dementia care in the future, a cost‐
effectiveness analysis of this program as well as a budget impact anal-
ysis should be conducted.
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In conclusion, the investigated in‐home respite care program was
effective in decreasing the desire of the caregiver to institutionalize
the care‐recipient after 6 months, but not the caregiver burden. In a
next step, longer‐term evidence is necessary to investigate if this
decreased desire leads to delayed institutionalization of the persons
with dementia. Furthermore, there will be a need for a health eco-
nomic evaluation of the program.
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